Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency

European Journal of Endocrinology

Volumn 157, Issue 5, 2007, Pages 589-596

  Hoybye, Charlotte ^a   Jönsson, Peter ^b   Monson, John P ^c   Kołtowska Häggström, Maria ^b,d   Hána, Václav ^e   Geffner, Mitchell ^f   Abs, Roger ^g  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b PFIZER INC   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UPPSALA UNIVERSITY   (Sweden)

^e CHARLES UNIVERSITY   (Czech Republic)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY HEIGHT; BRAIN TUMOR; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS DISEASE; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; BODY HEIGHT; DWARFISM, PITUITARY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MALE; PITUITARY NEOPLASMS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 36549030798     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0364     Document Type: Article

References (20)

1. de Boer H, Blok GJ & Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 1995 16 63-86.
2. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonennko P, Sönksen PH, Tanaka T & Thorner M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395.
3. Rosén T, Eden S, Larson G, Wilhelmsen L & Bengtsson B. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinologica 1993 129 195-200.
4. Bülow B, Hagmar L, Mikoczy Z, Nordstrom CH & Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology 1997 46 75-81.
5. Verhelst J & Abs R. Long-term growth hormone replacement therapy in hypopituitary adults. Drugs 2002 62 2399-2412.
6. Monson JP & Jonsson P. Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS. Hormone Research 2003 60 112-120.
7. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P & Wuster C. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. European Journal of Endocrinology 2002 146 67-74.
8. Kendall-Taylor P, Jonsson PJ, Abs R, Erforth EM, Koltowska-Haggstrom M, Price DA & Verhelst J. The clinical, metabolic and endocrine features and the quality of life in adults with childhoodonset craniopharyngioma compared with adult-onset craniopharyngioma. European Journal of Endocrinology 2005 152 557-567.
9. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM & Tauber M. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. European Journal of Endocrinology 2005 152 165-170.
10. Aetiology of growth hormone deficiency (KIMS classification list). In Growth Hormone Deficiency in Adults: 10 Years in Kims, Appendix D, pp 346-348. Eds R Abs & U Feldt-Rasmussen, Oxford: Oxford PharmaGenesis, 2004.
11. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
12. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L & Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research 1999 8 373-383.
13. Largo RH & Prader A. Pubertal development in Swiss boys. Helvetica Paediatrica Acta 1983 38 211-228.
14. Largo RH & Prader A. Pubertal development in Swiss girls. Helvetica Paediatrica Acta 1983 38 229-243.
15. Abdul Shakoor SK & Shalet SM. Effects of GH replacement on metabolism and physical performance in GH deficient adults. Journal of Endocrinological Investigation 2003 26 911-918.
16. Johannsson G, Albertsson-Wikland K & Bengtsson BA. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for growth hormone treatment in children. Journal of Clinical Endocrinology and Metabolism 1999 84 4516-4524.
17. Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O & Revel-Chion R. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents. Journal of Clinical Endocrinology and Metabolism 2001 86 1061-1065.
18. Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Goth MI, Koltowska-Haggstrom M, Monson JP, Verhelst J & Wilton P. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone and IGF Research 2005 15 349-359.
19. Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebi J, Chipman JJ & Shalet SM. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 2004 89 4857-4862.
20. Stouthart PJ, Deijen JB, Roffel M & Delemarre-van de Waal HA. Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psychoneuro-endocrinology 2003 28 612-626.